LOUISVILLE, CO, July 9, 2008 – GlobeImmune, Inc. announced today the signing of a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) at the National Institutes of Health (NIH) to jointly develop products intended to treat … Continue reading
GlobeImmune Signs CRADA with the National Institutes of Health to Develop Cancer Therapeutics
July 09, 2008